Copyright
©The Author(s) 2022.
World J Clin Oncol. Oct 24, 2022; 13(10): 802-812
Published online Oct 24, 2022. doi: 10.5306/wjco.v13.i10.802
Published online Oct 24, 2022. doi: 10.5306/wjco.v13.i10.802
Figure 2 Progression free survival.
5-year progression free survival (PFS) = 92.8%, 10-year PFS = 82.4%, and median follow-up time = 27.78 mo (1-181 mo). PFS: Progression-free survival.
- Citation: Rungoutok M, Suprasert P. Oncology and reproductive outcomes over 16 years of malignant ovarian germ cell tumors treated by fertility sparing surgery. World J Clin Oncol 2022; 13(10): 802-812
- URL: https://www.wjgnet.com/2218-4333/full/v13/i10/802.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i10.802